Personal beliefs and health care system barriers drive antibiotic use without a prescription, according to a new qualitative study.
Personal beliefs and health care system barriers drive antibiotic use without a prescription, according to a new qualitative study.
A newly approved vaccine can substantially reduce the clinical and economic burden of lower respiratory tract disease caused by RSV, according to new findings presented at IDWeek 2023.
IDSA and the HIVMA welcome the U.S. Preventive Services Task Force’s updated statement reaffirming and expanding its Grade A recommendation for pre-exposure prophylaxis for the prevention of HIV among adolescents and adults.
The Senate’s FY 2024 Labor, Health and Human Services and State and Foreign Operations appropriations bills largely flat fund ID programs at FY 2023 levels and provide a few modest increases.
IDSA is disappointed that the House Labor, Health and Human Services Subcommittee did not fund the Bio-Preparedness Workforce Pilot Program in its FY 2024 appropriations bill, missing an opportunity to close the widening ID workforce gap.
Dr. Marrazzo is an exceptional infectious diseases physician, leader, mentor and scientist who has dedicated her career to key areas of research, including sexually transmitted infections, HIV and antimicrobial resistance.
Breakthrough research presented at the International AIDS Society’s 2023 Conference on HIV Science in Brisbane, Australia this week demonstrates the significant advances and scientific achievements recently made in HIV science.
The Infectious Diseases Society of America is pleased to share the next step in its ongoing journey to reduce its environmental footprint. Beginning in January 2024, IDSA’s two print journals, Clinical Infectious Diseases and The Journal of Infectious Diseases, will move from 24 issues per year to 12.
IDSA and the HIVMA welcome President Biden’s appointment of Dr. Mandy Cohen to lead the U.S. Centers for Disease Control and Prevention. As the nation’s public health agency, CDC has a vital role in ensuring current and future health and preparedness.
IDSA is presenting its “2023 Legislative Impact Awards” to a bipartisan group of U.S. senators and representatives who have successfully led the passage of a new law or secured increased federal resources to address top IDSA priorities, including supporting the ID/HIV workforce and combating antimicrobial resistance.
The Infectious Diseases Society of America announced today the recipients of its Antimicrobial Stewardship Centers of Excellence designation.
The IDSA Foundation has named the George W. Counts, MD, FIDSA, Executive Conference room in honor of one of the country’s leading physicians, researchers, teachers, mentors and leaders.